United States - English - NLM (National Library of Medicine)

novartis ophthalmics - levocabastine hydrochloride (unii: 124xma6yei) (levocabastine - unii:h68bp06s81) - suspension - 0.5 mg in 1 ml - livostin™ 0.05% (levocabastine hydrochloride ophthalmic suspension) is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. this product is contraindicated in persons with known or suspected hypersensitivity to any of its components. it should not be used while soft contact lenses are being worn.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - levocabastine hydrochloride, quantity: 0.54 mg/ml (equivalent: levocabastine, qty 0.5 mg/ml) - spray, nasal - excipient ingredients: disodium edetate; polysorbate 80; hypromellose; monobasic sodium phosphate; purified water; propylene glycol; benzalkonium chloride; dibasic sodium phosphate - symptomatic treatment of seasonal or perennial allergic rhinitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - levocabastine hydrochloride, quantity: 0.54 mg/ml (equivalent: levocabastine, qty 0.5 mg/ml) - eye drops, suspension - excipient ingredients: hypromellose; disodium edetate; benzalkonium chloride; polysorbate 80; propylene glycol; dibasic sodium phosphate; monobasic sodium phosphate; water for injections - symptomatic treatment of seasonal allergic conjunctivitis.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sanwa kagaku kenkyusho co.,ltd. - levocabastine hydrochloride - white suspended ophthalmic solution, (bottle cap) white, (bottle) colorless transparent

Malta - English - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - levocabastine hydrochloride - eye drops, solution - levocabastine hydrochloride 0.5 mg/ml - ophthalmologicals

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - levocabastine hydrochloride, quantity: 0.54 mg/ml (equivalent: levocabastine, qty 0.5 mg/ml) - spray, nasal - excipient ingredients: monobasic sodium phosphate; hypromellose; purified water; polysorbate 80; benzalkonium chloride; dibasic sodium phosphate; disodium edetate; propylene glycol - for use in the following conditions: nasal spray: short-term use in seasonal or perennial allergic rhinitis. indications as at 14 august 1996: symptomatic treatment of seasonal or perennial allergic rhinitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - levocabastine hydrochloride, quantity: 0.54 mg/ml (equivalent: levocabastine, qty 0.5 mg/ml) - eye drops, suspension - excipient ingredients: benzalkonium chloride; water for injections; disodium edetate; dibasic sodium phosphate; monobasic sodium phosphate; polysorbate 80; hypromellose; propylene glycol - for the use in the following conditions: eye drops: symptomatic treatment of seasonal allergic conjunctivitis. nasal spray: short-term use in seasonal or perennial allergic rhinitis. indications as at 14 august 1996: symptomatic treatment of seasonal or perennial allergic rhinitis.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

senju pharmaceutical co.,ltd. - levocabastine hydrochloride - white ophthalmic suspension; (cap) cream

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kyosomirai pharma co., ltd. - levocabastine hydrochloride - white (suspension) ophthalmic solution, (cap) white, (bottle) colorless

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - levocabastine hydrochloride - white ophthalmic solution,(cap) blue, (bottle) colorless